Source: Virtual Congress 2020 – Challenging issues in thoracic surgery
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
M. Drösslerová (Prague, Czech Republic), M. Šterclová (Prague, Czech Republic), M. Vašáková (Prague, Czech Republic), A. Tašková (Prague, Czech Republic), V. Hytych (Prague, Czech Republic), E. Richterová (Prague, Czech Republic), M. Matejcková (Prague, Czech Republic). Role of chemokines, their gene polymorphisms in resectable NSCLC. 4094

Member's Comments

No comment yet.

Related content which might interest you: Polymorphisms in the interleukin-10 gene promoter are associated with susceptibility to non-small cell lung cancer (NSCLC) Source: Eur Respir J 2005; 26: Suppl. 49, 458s Year: 2005 Role of chemokines in resectable non-small cell lung cancer (NSCLC) Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019 Investigation of survivin gene polymorphism in non-small cell lung cancer patients (NSCLC) Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 Single nucleotide polymorphisms in matrix metalloproteinase genes and lung cancer chemotherapy response and prognosis Source: Eur Respir J 2010; 35: 381-390 Year: 2010 Association between polymorphisms in microRNA target sites using CLASH data and survival of early-stage non-small cell lung cancer Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells Year: 2017 Arg72Pro P53 gene polymorphism as a predisposing factor for non-small cell lung cancer (NSCLC) development Source: Eur Respir J 2004; 24: Suppl. 48, 78s Year: 2004 Investigation of a relationship between NF-KB1A gene polymorphism and non small cell lung cancer (NSCLC) Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 Polymorphism in GSTM1, GSTT1, p53 and CCR5 genes and lung cancer progression: relation to p53 and Ki-67 protein expression in tumors of non-small cell lung cancer patients Source: Eur Respir J 2006; 28: Suppl. 50, 810s Year: 2006 Analysis of XPD gene Lys751Gln polymorphism as predisposing factor for non-small cell lung cancer (NSCLC) development Source: Eur Respir J 2007; 30: Suppl. 51, 131s Year: 2007 Role of EBUS-TBNA in the study of PD-L1 expression in patients with non-small cell lung cancer (NSCLC) Source: Virtual Congress 2020 – Endobronchial ultrasound: from rookie to pro Year: 2020 Evaluation of EGFR mutations and ERCC2 polymorphisms in treatment of non-small cell lung cancer Source: Annual Congress 2005 - Chemotherapy and palliative care Year: 2005 Arg72Pro P53 gene polymorphism is associated with P53 mutations in non-small cell lung cancer (NSCLC) patients Source: Eur Respir J 2004; 24: Suppl. 48, 78s Year: 2004 A polymorphism, which exists intronic lesion of SLC5A10, affects DRG2 expression and survival outcome of early-stage non-small cell lung cancer Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Are Vitamin D receptor genetic polymorphisms associated with chemotherapy response and prognosis in patients with advanced non-small-cell lung cancer? Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016 Prognostic value of ERCC1 expression in advanced non-small cell lung cancer (NSCLC) Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012 Association of polymorphism of the human nm23-H1 gene (NME1) with susceptibility to and severity of non-small cell lung cancer Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology Year: 2007 Macrophage expression of interleukin-10 is a prognostic factor in nonsmall cell lung cancer Source: Eur Respir J 2007; 30: 627-632 Year: 2007 Polymorphisms in mitotic checkpoint-related genes can influence survival outcomes of early-stage non-small cell lung cancer Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors Year: 2017 The association of MMP-7 and MMP-13 genetic polymorphisms with susceptibility to non-small cell lung cancer in Taiwan Source: Annual Congress 2008 - Biology in thoracic tumours Year: 2008 Association of KIR genes and their ligands with non-small cell lung cancer Source: Annual Congress 2010 - Prognostic factors for lung cancer Year: 2010